PROSTAGLANDIN-E(2) RESTORES CANCELLOUS BONE TO IMMOBILIZED LIMB AND ADDS BONE TO OVERLOADED LIMB IN RIGHT HINDLIMB IMMOBILIZATION RATS

被引:26
|
作者
LI, M [1 ]
JEE, WSS [1 ]
KE, HZ [1 ]
LIANG, XG [1 ]
LIN, BY [1 ]
MA, YF [1 ]
SETTERBERG, RB [1 ]
机构
[1] UNIV UTAH,SCH MED,DIV RADIOBIOL,BLDG 586,SALT LAKE CITY,UT 84112
关键词
D O I
10.1016/8756-3282(93)90153-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to determine whether prostaglandin E2 (PGE2) can restore cancellous bone mass and architecture to osteopenic, continuously immobilized (IM), proximal tibial metaphysis (PTM) in female rats. The right hindlimb of three and one-half-month-old Sprague-Dawley female rats were immobilized by right hindlimb immobilization (RHLI) in which the right hindlimb was underloaded and the contralateral left limb was overloaded during ambulation. After 4 or 12 weeks of RHLI, the rats were treated with 3 or 6 mg PGE2/kg/day and RHLI for 8 or 16 weeks. Bone histomorphometry was performed on microradiographs of PTM. Immobilization (IM) induced a transient cancellous bone loss and decreased trabecular thickness, number and node density, and increased free end density that established a new steady state after 4 weeks of IM. Three or 6 mg PGE2/kg/d for 8 weeks beginning at 4 or 12 weeks of IM completely restored cancellous bone mass (+127% to +188%) and structure to the age-related control levels in spite of continuous IM. Another 8 weeks of treatment maintained bone mass and architecture at these levels. No differences in cancellous bone mass and architecture were found between the overloaded PTM or RHLI rats and the age-related controls. However, 3 and 6 mg/kg/d of PGE2 treatment started at 4 or 12 weeks for 8 weeks significantly increased cancellous bone mass in the overloaded PTM (+45 to +74% of untreated controls), and another 8 weeks of treatment maintained bone mass at these levels. Our findings indicate that daily 3 or 6 mg PGE2/kg/d treatment restores and maintains PTM cancellous bone mass in continuously immobilized (right) tibiae, and adds and maintains extra bone to slightly overloaded PTM cancellous bone in female rats.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 50 条
  • [31] PROSTAGLANDIN E(2) ADMINISTRATION PREVENTS BONE LOSS INDUCED BY ORCHIECTOMY IN RATS
    LI, M
    JEE, WSS
    KE, HZ
    TANG, LY
    MA, YF
    LIANG, XG
    SETTERBERG, RB
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 (01) : 66 - 73
  • [32] A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats
    Ke, HZ
    Crawford, DT
    Qi, H
    Simmons, HA
    Owen, TA
    Paralkar, VM
    Li, M
    Lu, BH
    Grasser, WA
    Cameron, KO
    Lefker, LA
    DaSilva-Jardine, P
    Scott, DO
    Zhang, Q
    Tian, XY
    Jee, WSS
    Brown, TA
    Thompson, DD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (04) : 565 - 575
  • [33] PROSTAGLANDIN-E(2) ADMINISTERED BY SUBCUTANEOUS PELLETS CAUSES LOCAL INFLAMMATION AND SYSTEMIC BONE LOSS - A MODEL FOR INFLAMMATION-INDUCED BONE-DISEASE
    DESIMONE, DP
    GREENE, VS
    HANNON, KS
    TURNER, RT
    BELL, NH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (05) : 625 - 634
  • [34] PRODUCTION OF NEW TRABECULAR BONE IN OSTEOPENIC OVARIECTOMIZED RATS BY PROSTAGLANDIN-E2
    MORI, S
    JEE, WSS
    LI, XJ
    CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (01) : 80 - 87
  • [35] Anabolic effect of prostaglandin E2 in bone is not dependent on pituitary hormones in rats
    Chen, MM
    Yeh, JK
    Aloia, JF
    CALCIFIED TISSUE INTERNATIONAL, 1998, 63 (03) : 236 - 242
  • [36] Anabolic Effect of Prostaglandin E2 in Bone Is not Dependent on Pituitary Hormones in Rats
    M. M. Chen
    J. K. Yeh
    J. F. Aloia
    Calcified Tissue International, 1998, 63 : 236 - 242
  • [37] TRANSIENT EFFECTS OF SUBCUTANEOUSLY ADMINISTERED PROSTAGLANDIN-E2 ON CANCELLOUS AND CORTICAL BONE IN YOUNG-ADULT DOGS
    LI, XJ
    JEE, WSS
    LI, YL
    PATTERSONBUCKENDAHL, P
    BONE, 1990, 11 (05) : 353 - 364
  • [38] Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia
    Ke, HZ
    Shen, VW
    Qi, H
    Crawford, DT
    Wu, DD
    Liang, XG
    Chidsey-Frink, KL
    Pirie, CM
    Simmons, HA
    Thompson, DD
    BONE, 1998, 23 (03) : 249 - 255
  • [39] Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2
    Ozturk, AM
    Cila, E
    Kanatli, U
    Isik, I
    Senkoylu, A
    Uzunok, D
    Piskin, E
    INTERNATIONAL ORTHOPAEDICS, 2005, 29 (02) : 73 - 77
  • [40] Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats
    Mosekilde, L
    Thomsen, JS
    Mackey, MS
    Phipps, RJ
    BONE, 2000, 27 (05) : 639 - 645